Clinical Trial Update: Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II) [Phase 3]

View source ↗

Summary

Phase 3 COSTAR II trial evaluating a cobalt-chromium stent with antiproliferative coating for restenosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cobalt Chromium Stent With Antiproliferative

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Disease | Phase 3 | Status: COMPLETED